1
|
Ji Z, Liao L, Ge Y, Liu M, Fang X, Sun H, Zheng S, Deng X. Screening anabolic androgenic steroids in human urine: an application of the state-of-the-art gas chromatography-Orbitrap high-resolution mass spectrometry. Anal Bioanal Chem 2024; 416:3223-3237. [PMID: 38573345 DOI: 10.1007/s00216-024-05272-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2024] [Revised: 03/11/2024] [Accepted: 03/25/2024] [Indexed: 04/05/2024]
Abstract
Over the past few decades, anabolic androgenic steroids (AASs) have been abused in and out of competition for their performance-enhancing and muscle-building properties. Traditionally, AASs were commonly detected using gas chromatography-mass spectrometry in the initial testing procedure for doping control purposes. Gas chromatography-Orbitrap high-resolution mass spectrometry (GC-Orbitrap-HRMS) is a new technology that has many advantages in comparison with GC-MS (e.g., a maximum resolving power of 240,000 (FWHM at m/z 200), excellent sub-ppm mass accuracy, and retrospective data analysis after data acquisition). Anti-doping practitioners are encouraged to take full advantage of the updated techniques of chromatography-mass spectrometry to develop sensitive, specific, and rapid screening methods for AASs. A new method for screening a wide range of AASs in human urine using GC-Orbitrap-HRMS was developed and validated. The method can qualitatively determine 70 anabolic androgenic steroids according to the minimum required performance limit of the World Anti-Doping Agency. Moreover, the validated method was successfully applied to detect six metabolites in urine after the oral administration of metandienone, and their excretion curves in vivo were studied. Metandienone M6 (17β-hydroxymethyl-17α-methyl-18-nor-androst-1,4,13-trien-3-one) has been identified as a long-term urinary metabolite which can be detected up to 7 weeks, thus providing a longer detection window compared with previous studies. This study provides a rationale for GC-Orbitrap-HRMS in drug metabolism and non-targeted screening.
Collapse
Affiliation(s)
- Ziyi Ji
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| | - Lei Liao
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China.
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China.
| | - Yuqi Ge
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| | - Mengpan Liu
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| | - Xian Fang
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| | - Haoyi Sun
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| | - Siying Zheng
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| | - Xiaojun Deng
- School of Kinesiology, Shanghai University of Sport, 399 Changhai Road, Shanghai, 200438, People's Republic of China
- Shanghai Anti-doping Laboratory, 900 Xinjiangwancheng Road, Shanghai, 200438, People's Republic of China
| |
Collapse
|
2
|
Abstract
This paper aims to cover the main strategies based on ion mobility spectrometry (IMS) for the analysis of biological samples. The determination of endogenous and exogenous compounds in such samples is important for the understanding of the health status of individuals. For this reason, the development of new approaches that can be complementary to the ones already established (mainly based on liquid chromatography coupled to mass spectrometry) is welcomed. In this regard, ion mobility spectrometry has appeared in the analytical scenario as a powerful technique for the separation and characterization of compounds based on their mobility. IMS has been used in several areas taking advantage of its orthogonality with other analytical separation techniques, such as liquid chromatography, gas chromatography, capillary electrophoresis, or supercritical fluid chromatography. Bioanalysis is not one of the areas where IMS has been more extensively applied. However, over the last years, the interest in using this approach for the analysis of biological samples has clearly increased. This paper introduces the reader to the principles controlling the separation in IMS and reviews recent applications using this technique in the field of bioanalysis.
Collapse
|
3
|
Wan R, Kong X, Yang Y, Tao S, Chen Y, Teichmann AT, Wieland FH. Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator Formestane. J Steroid Biochem Mol Biol 2020; 198:105527. [PMID: 31733346 DOI: 10.1016/j.jsbmb.2019.105527] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2019] [Revised: 10/31/2019] [Accepted: 11/03/2019] [Indexed: 10/25/2022]
Abstract
The clinical use of the steroidal aromatase inhibitor Formestane (4-hydroxandrostenedione, 4-OHA) in the treatment of advanced ER+ breast cancer has been discontinued, and therefore, interest in this remarkable drug has vanished. As a C-19 sterol, 4-OHA can undergo extensive intracellular metabolism depending on the expression of specific enzymes in the corresponding cells. We used the metabolites 4β-hydroxyandrosterone, 4β-hydroxyepiandrosterone and its 17β-reduced derivative as standards for the proof of catalytic activity present in the cell culture medium and expressed by the isolated enzymes. All of the aldo-keto reductases AKR1C1, AKR1C2, AKR1C3 and AKR1C4 catalysed the reduction of the 3-keto-group and the Δ4,5 double bond of 4-OHA at the same time. Molecular docking experiments using microscale thermophoresis and the examination of the kinetic behaviour of the isolated enzymes with the substrate 4-OHA proved that AKR1C3 had the highest affinity for the substrate, whereas AKR1C1 was the most efficient enzyme. Both enzymes (AKR1C1and AKR1C3) are highly expressed in adipose tissue and lungs, exhibiting 3β-HSD activity. The possibility that 4-OHA generates biologically active derivatives such as the androgen 4-hydroxytestosterone or some 17β-hydroxy derivatives of the 5α-reduced metabolites may reawaken interest in Formestane, provided that a suitable method of administration can be developed, avoiding oral or intramuscular depot-injection administration.
Collapse
Affiliation(s)
- Runlan Wan
- Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China; Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China; Key Laboratory of the Ministry of Education for Medical Electrophysiology, Southwest Medical University, Luzhou, 646000, China
| | - Xi Kong
- Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
| | - Youzhe Yang
- Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
| | - Siwen Tao
- School of Pharmacy, Southwest Medical University, Luzhou 646000, China
| | - Youyou Chen
- Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
| | - Alexander Tobias Teichmann
- Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
| | - Frank Heinrich Wieland
- Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
| |
Collapse
|
4
|
Saurina J, Sentellas S. Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery. Expert Opin Drug Discov 2019; 14:469-483. [DOI: 10.1080/17460441.2019.1582638] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Javier Saurina
- Department of Chemical Engineering and Analytical Chemistry, University of Barcelona, Barcelona, Spain
| | - Sonia Sentellas
- Department of Chemical Engineering and Analytical Chemistry, University of Barcelona, Barcelona, Spain
| |
Collapse
|
5
|
Honour JW, Conway E, Hodkinson R, Lam F. The evolution of methods for urinary steroid metabolomics in clinical investigations particularly in childhood. J Steroid Biochem Mol Biol 2018; 181:28-51. [PMID: 29481855 DOI: 10.1016/j.jsbmb.2018.02.013] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2017] [Revised: 02/21/2018] [Accepted: 02/21/2018] [Indexed: 12/15/2022]
Abstract
The metabolites of cortisol, and the intermediates in the pathways from cholesterol to cortisol and the adrenal sex steroids can be analysed in a single separation of steroids by gas chromatography (GC) coupled to MS to give a urinary steroid profile (USP). Steroids individually and in profile are now commonly measured in plasma by liquid chromatography (LC) coupled with MS/MS. The steroid conjugates in urine can be determined after hydrolysis and derivative formation and for the first time without hydrolysis using GC-MS, GC-MS/MS and liquid chromatography with mass spectrometry (LC-MS/MS). The evolution of the technology, practicalities and clinical applications are examined in this review. The patterns and quantities of steroids changes through childhood. Information can be obtained on production rates, from which children with steroid excess and deficiency states can be recognised when presenting with obesity, adrenarche, adrenal suppression, hypertension, adrenal tumours, intersex condition and early puberty, as examples. Genetic defects in steroid production and action can be detected by abnormalities from the GC-MS of steroids in urine. New mechanisms of steroid synthesis and metabolism have been recognised through steroid profiling. GC with tandem mass spectrometry (GC-MS/MS) has been used for the tentative identification of unknown steroids in urine from newborn infants with congenital adrenal hyperplasia. Suggestions are made as to areas for future research and for future applications of steroid profiling. As routine hospital laboratories become more familiar with the problems of chromatographic and MS analysis they can consider steroid profiling in their test repertoire although with LC-MS/MS of urinary steroids this is unlikely to become a routine test because of the availability, cost and purity of the internal standards and the complexity of data interpretation. Steroid profiling with quantitative analysis by mass spectrometry (MS) after chromatography now provides the most versatile of tests of adrenal function in childhood.
Collapse
Affiliation(s)
- John W Honour
- Institute for Women's Health, University College London, 74 Huntley Street, London, WC1E 6AU, UK.
| | - E Conway
- Clinical Biochemistry, HSL Analytics LLP, Floor 2, 1 Mabledon Place, London, WC1H 9AX, UK
| | - R Hodkinson
- Clinical Biochemistry, HSL Analytics LLP, Floor 2, 1 Mabledon Place, London, WC1H 9AX, UK
| | - F Lam
- Clinical Biochemistry, HSL Analytics LLP, Floor 2, 1 Mabledon Place, London, WC1H 9AX, UK
| |
Collapse
|
6
|
Polet M, Van Gansbeke W, Geldof L, Deventer K, Van Eenoo P. Identification and characterization of novel long‐term metabolites of oxymesterone and mesterolone in human urine by application of selected reaction monitoring GC‐CI‐MS/MS. Drug Test Anal 2017; 9:1673-1684. [DOI: 10.1002/dta.2183] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 03/02/2017] [Accepted: 03/02/2017] [Indexed: 12/12/2022]
Affiliation(s)
- Michael Polet
- Department of Clinical Chemistry, Microbiology and Immunology, Doping Control LaboratoryGhent University Technologiepark 30 B B‐9052 Zwijnaarde Belgium
| | - Wim Van Gansbeke
- Department of Clinical Chemistry, Microbiology and Immunology, Doping Control LaboratoryGhent University Technologiepark 30 B B‐9052 Zwijnaarde Belgium
| | - Lore Geldof
- Department of Clinical Chemistry, Microbiology and Immunology, Doping Control LaboratoryGhent University Technologiepark 30 B B‐9052 Zwijnaarde Belgium
| | - Koen Deventer
- Department of Clinical Chemistry, Microbiology and Immunology, Doping Control LaboratoryGhent University Technologiepark 30 B B‐9052 Zwijnaarde Belgium
| | - Peter Van Eenoo
- Department of Clinical Chemistry, Microbiology and Immunology, Doping Control LaboratoryGhent University Technologiepark 30 B B‐9052 Zwijnaarde Belgium
| |
Collapse
|
7
|
Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal 2017; 9:6-29. [DOI: 10.1002/dta.2139] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2016] [Accepted: 11/21/2016] [Indexed: 12/17/2022]
Affiliation(s)
- Mario Thevis
- Center for Preventive Doping Research - Institute of Biochemistry; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
- European Monitoring Center for Emerging Doping Agents; Cologne Germany
| | - Tiia Kuuranne
- Swiss Laboratory for Doping Analyses; University Center of Legal Medicine; Genève and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne Epalinges Switzerland
| | - Hans Geyer
- Center for Preventive Doping Research - Institute of Biochemistry; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
- European Monitoring Center for Emerging Doping Agents; Cologne Germany
| | - Wilhelm Schänzer
- Center for Preventive Doping Research - Institute of Biochemistry; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| |
Collapse
|